Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update

Korde, LA; Somerfield, MR; Hershman, DL

Somerfield, MR (通讯作者),Amer Soc Clin Oncol, 2318 Mill Rd,Suite 800, Alexandria, VA 22314 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (15): 1696

Abstract

ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-cha......

Full Text Link